Further key findings from the study suggest:
- Single specialty OBLs spearheaded the market in 2019, whereas hybrid office-based labs are anticipated to witness high growth during the forecast period. Single-specialty labs offer more patient-centric treatments while hybrid models offer more profitability with multiple facilities under one roof
- Peripheral Vascular Intervention (PVI) service segment dominated the U.S. office-based labs market in 2019, owing to a high prevalence of atherosclerosis in the country. A large number of balloon angioplasty and stenting procedures for blocked arteries and veins has also aided segment growth
- Vascular surgeons are leading specialist service providers in OBLs and the segment held a major market share in 2019, attributed to the rising burden of vascular diseases in the country. All the major vascular surgeries such as aortic, mesenteric, renal, subclavian, iliofemoral, tibia, and pedal are performed by vascular surgeons in office settings
- In U.S., almost 70% of surgical procedures are performed in outpatient settings, out of which, around 25% are performed in physicians’ office
- Key suppliers of vascular intervention devices include Abbott; Medtronic; Boston Scientific; and Cardiovascular System, Inc.; and Cardinal Health, Inc. Mergers and acquisition, technological advancements, and new product launch are some of the strategies followed by major players in the market.
In August 2019, Boston Scientific acquired BTG PLC to expand its portfolio of minimally-invasive surgical devicesTop Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members
Copyright © 2020 Uberant.com800,224 total articles and counting.